Zingg Patrick O, Fucentese Sandro F, Lutz Willy, Brand Brigit, Mamisch Nadja, Koch Peter P
Division of Knee Surgery, Department of Orthopaedics, University of Zurich Balgrist, Forchstrasse 340, 8008, Zürich, Switzerland.
Knee Surg Sports Traumatol Arthrosc. 2012 Dec;20(12):2465-70. doi: 10.1007/s00167-012-1896-7.
The objective of this study was to evaluate the long-term outcome and prosthetic survival of primary total knee arthroplasty in haemophilic patients. It was hypothesized that the infection and revision rate are higher and the outcome inferior when compared with patients without haemophilia.
Between 1985 and 2004, forty-three consecutive primary total knee replacements were performed in thirty haemophilic patients. These patients' charts were reviewed retrospectively. Twenty-five patients (34 knees) were available for clinical and radiological follow-up. The outcome was assessed using the Knee Society score, WOMAC and Kaplan-Meier survivorship analysis.
An haematogenous infection occurred in two patients. In three patients, component revision was needed: two because of an infection and one because of a mechanical failure. After a mean follow-up of 9.6 years (2-20), 94% of the patients rated their result as either excellent or good. At time of follow-up, the Knee Society Score averaged 73.3 points (range, 29-100) and showed a significant gain (p < 0.001) compared to preoperative. Flexion contracture could be reduced significantly (p < 0.001) from 18.1° preoperatively to 8.4° at follow-up, whereas flexion remained unchanged. When infection or any component replacement was set as endpoints, the 10 years prosthetic survival was 90 and 86%, respectively.
Total knee arthroplasty in haemophilic patients is a reliable treatment that results in pain relief and functional improvement with a low risk of postoperative infection. However, neither the postoperative infection rate nor the functional result does reach the same level as in a population not affected by haemophilia.
IV.
本研究的目的是评估血友病患者初次全膝关节置换术的长期疗效和假体生存率。研究假设是,与非血友病患者相比,血友病患者的感染率和翻修率更高,疗效更差。
1985年至2004年期间,对30例血友病患者连续实施了43例初次全膝关节置换术。对这些患者的病历进行了回顾性分析。25例患者(34个膝关节)接受了临床和影像学随访。采用膝关节协会评分、WOMAC评分和Kaplan-Meier生存分析评估疗效。
2例患者发生血源性感染。3例患者需要进行假体翻修:2例因感染,1例因机械故障。平均随访9.6年(2 - 20年)后,94%的患者将其结果评为优秀或良好。随访时,膝关节协会评分平均为73.3分(范围29 - 100分),与术前相比有显著提高(p < 0.001)。屈曲挛缩可从术前的18.1°显著降低(p < 0.001)至随访时的8.4°,而屈曲度保持不变。以感染或任何假体置换作为终点时,10年假体生存率分别为90%和86%。
血友病患者的全膝关节置换术是一种可靠的治疗方法,可缓解疼痛并改善功能,术后感染风险较低。然而,术后感染率和功能结果均未达到未受血友病影响人群的水平。
IV级。